Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Chronic Kidney Disease | Research

Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry

Authors: Yun-Kai Yeh, Kuan-Hung Lin, Wayne Huey-Herng Sheu, Su-Huey Lo, Yen-Po Yeh, Chien-Ning Huang, Chii-Min Hwu, Chieh-Hsiang Lu

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

We tried to identify the risk factor associate with early chronic kidney disease (CKD) in recently diagnosed type 2 diabetes mellitus patients by utilizing real-world data from Taiwan Diabetes Registry.

Materials and methods

Patients with type 2 diabetes mellitus recently diagnosed within 1 year. We divided the study participants into control group and early CKD group. Early CKD was defined as either CKD stage G1 with albuminuria, CKD stage G2 with albuminuria, or CKD stage G3a regardless of albuminuria (Urine-albumin to creatinine ratio (UACR) ≥ 3 mg/mmol). Control group was defined as CKD G1 or CKD G2 without albuminuria. Logistic regression analyses were used to compare differences in clinical characteristics between the subgroups. Linear regression models were employed to examine the factors predicting estimated glomerular filtration rate (eGFR) and UACR.

Results

Total 2217 patients with recently diagnosed type 2 diabetes mellitus were included. 1545 patients were assigned to control group and 618 patients were assigned to the early CKD group. Age (odds ratio (OR) 1.215, 95% confidence interval [CI] 1.122–1.316), systolic blood pressure (OR 1.203, 95% CI 1.117–1.296), glycated hemoglobin (OR 1.074, 95% CI 1.023–1.129) and triglyceride (OR 2.18, 95% CI 1.485–3.199) were found to be significant risk factors. Further, presence of bidirectional association between UACR and eGFR was found.

Conclusions

We reported factors associated with early CKD in recently diagnosed type 2 diabetes mellitus patients. Variables that associated with eGFR and UACR were identified respectively, included a mutual influence between UACR and eGFR.
Appendix
Available only for authorised users
Literature
1.
go back to reference King H, Rewers M. Global estimates for prevalence of diabetes Mellitus and impaired glucose tolerance in adults. Diabetes Care. 1993;16(1):157–77.CrossRefPubMed King H, Rewers M. Global estimates for prevalence of diabetes Mellitus and impaired glucose tolerance in adults. Diabetes Care. 1993;16(1):157–77.CrossRefPubMed
2.
go back to reference An J, Nichols GA, Qian L, et al. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1):e001847.CrossRefPubMedPubMedCentral An J, Nichols GA, Qian L, et al. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1):e001847.CrossRefPubMedPubMedCentral
3.
go back to reference Höskuldsdóttir G, Franzén S, Eeg-Olofsson K et al. Risk trajectories of complications in over one thousand newly diagnosed individuals with type 2 diabetes. Sci Rep. 2022;12(1). Höskuldsdóttir G, Franzén S, Eeg-Olofsson K et al. Risk trajectories of complications in over one thousand newly diagnosed individuals with type 2 diabetes. Sci Rep. 2022;12(1).
5.
go back to reference Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93–104.CrossRefPubMedPubMedCentral Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93–104.CrossRefPubMedPubMedCentral
6.
go back to reference Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney International. 2011;80(1):17–28. Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney International. 2011;80(1):17–28.
7.
go back to reference Go AS, Chertow GM, Fan D, et al. Chronic kidney Disease and the risks of Death, Cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.CrossRefPubMed Go AS, Chertow GM, Fan D, et al. Chronic kidney Disease and the risks of Death, Cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.CrossRefPubMed
8.
go back to reference Rossing P, Caramori ML, Chan JC, et al. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5):S1–127.CrossRef Rossing P, Caramori ML, Chan JC, et al. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5):S1–127.CrossRef
9.
go back to reference Gæde P, Vedel P, Larsen N, et al. Multifactorial intervention and Cardiovascular Disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–93.CrossRefPubMed Gæde P, Vedel P, Larsen N, et al. Multifactorial intervention and Cardiovascular Disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–93.CrossRefPubMed
10.
go back to reference Gæde P, Oellgaard J, Carstensen B, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia. 2016;59(11):2298–307.CrossRefPubMedPubMedCentral Gæde P, Oellgaard J, Carstensen B, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia. 2016;59(11):2298–307.CrossRefPubMedPubMedCentral
11.
go back to reference Wouters OJ, O’Donoghue DJ, Ritchie J, et al. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol. 2015;11(8):491–502.CrossRefPubMedPubMedCentral Wouters OJ, O’Donoghue DJ, Ritchie J, et al. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol. 2015;11(8):491–502.CrossRefPubMedPubMedCentral
12.
go back to reference Wang JS, Yen FS, Lin KD, et al. Epidemiological characteristics of diabetic kidney disease in Taiwan. J Diabetes Invest. 2021;12(12):2112–23.CrossRef Wang JS, Yen FS, Lin KD, et al. Epidemiological characteristics of diabetic kidney disease in Taiwan. J Diabetes Invest. 2021;12(12):2112–23.CrossRef
13.
go back to reference Geletu AH, Teferra AS, Sisay MM et al. Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul’s Hospital, Addis Ababa, Ethiopia. BMC Research Notes. 2018;11(1). Geletu AH, Teferra AS, Sisay MM et al. Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul’s Hospital, Addis Ababa, Ethiopia. BMC Research Notes. 2018;11(1).
14.
go back to reference Aboelnasr M, Shaltout A, AlSheikh M, et al. Diabetic kidney disease in patients newly diagnosed with type-2 diabetes mellitus: incidence and associations. Saudi J Kidney Dis Transplantation. 2020;31(1):191.CrossRef Aboelnasr M, Shaltout A, AlSheikh M, et al. Diabetic kidney disease in patients newly diagnosed with type-2 diabetes mellitus: incidence and associations. Saudi J Kidney Dis Transplantation. 2020;31(1):191.CrossRef
15.
go back to reference Kuo CF, Yu KH, Shen YM, et al. The Chinese version of the modification of diet in renal disease (MDRD) equation is a superior screening tool for chronic kidney disease among middle-aged Taiwanese than the original MDRD and Cockcroft-Gault equations. Biomed J. 2014;37(6):398–405.CrossRefPubMed Kuo CF, Yu KH, Shen YM, et al. The Chinese version of the modification of diet in renal disease (MDRD) equation is a superior screening tool for chronic kidney disease among middle-aged Taiwanese than the original MDRD and Cockcroft-Gault equations. Biomed J. 2014;37(6):398–405.CrossRefPubMed
16.
go back to reference Bramlage P, Lanzinger S, van Mark G, et al. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases. Cardiovasc Diabetol. 2019;18(1):33.CrossRefPubMedPubMedCentral Bramlage P, Lanzinger S, van Mark G, et al. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases. Cardiovasc Diabetol. 2019;18(1):33.CrossRefPubMedPubMedCentral
17.
go back to reference Jitraknatee J, Ruengorn C, Nochaiwong S. Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: a cross-sectional study in primary care practice. Sci Rep. 2020;10(1):6205.CrossRefPubMedPubMedCentral Jitraknatee J, Ruengorn C, Nochaiwong S. Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: a cross-sectional study in primary care practice. Sci Rep. 2020;10(1):6205.CrossRefPubMedPubMedCentral
18.
go back to reference Staplin N, Herrington WG, Murgia F, et al. Determining the relationship between blood pressure, kidney function, and chronic kidney disease: insights from genetic epidemiology. Hypertension. 2022;79(12):2671–81.CrossRefPubMed Staplin N, Herrington WG, Murgia F, et al. Determining the relationship between blood pressure, kidney function, and chronic kidney disease: insights from genetic epidemiology. Hypertension. 2022;79(12):2671–81.CrossRefPubMed
20.
go back to reference Melsom T, Mathisen UD, Ingebretsen OC, et al. Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care. 2011;34(7):1546–51.CrossRefPubMedPubMedCentral Melsom T, Mathisen UD, Ingebretsen OC, et al. Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care. 2011;34(7):1546–51.CrossRefPubMedPubMedCentral
21.
go back to reference Lee C-L, Li T-C, Lin S-Y, et al. Dynamic and dual effects of Glycated Hemoglobin on estimated glomerular filtration rate in type 2 Diabetic outpatients. Am J Nephrol. 2013;38(1):19–26.CrossRefPubMed Lee C-L, Li T-C, Lin S-Y, et al. Dynamic and dual effects of Glycated Hemoglobin on estimated glomerular filtration rate in type 2 Diabetic outpatients. Am J Nephrol. 2013;38(1):19–26.CrossRefPubMed
22.
go back to reference Kawamoto R, Kohara K, Tabara Y, et al. An association between body Mass Index and estimated glomerular filtration rate. Hypertens Res. 2008;31(8):1559–64.CrossRefPubMed Kawamoto R, Kohara K, Tabara Y, et al. An association between body Mass Index and estimated glomerular filtration rate. Hypertens Res. 2008;31(8):1559–64.CrossRefPubMed
23.
go back to reference Luk AO, So WY, Ma RC, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care. 2008;31(12):2357–61.CrossRefPubMedPubMedCentral Luk AO, So WY, Ma RC, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care. 2008;31(12):2357–61.CrossRefPubMedPubMedCentral
24.
go back to reference Jiang Y, Jia J, Li J, et al. Impaired fasting blood glucose is associated with incident albuminuria: data from a Chinese community-based cohort. J Diabetes Complicat. 2022;36(2):108125.CrossRef Jiang Y, Jia J, Li J, et al. Impaired fasting blood glucose is associated with incident albuminuria: data from a Chinese community-based cohort. J Diabetes Complicat. 2022;36(2):108125.CrossRef
25.
go back to reference Wang Y-X, Wang A-P, Ye Y-N et al. Elevated triglycerides rather than other lipid parameters are associated with increased urinary albumin to creatinine ratio in the general population of China: a report from the REACTION study. Cardiovasc Diabetol. 2019;18(1). Wang Y-X, Wang A-P, Ye Y-N et al. Elevated triglycerides rather than other lipid parameters are associated with increased urinary albumin to creatinine ratio in the general population of China: a report from the REACTION study. Cardiovasc Diabetol. 2019;18(1).
26.
go back to reference Pasternak M, Liu P, Quinn R, et al. Association of Albuminuria and regression of chronic kidney disease in adults with newly diagnosed moderate to severe chronic kidney disease. JAMA Netw Open. 2022;5(8):e2225821.CrossRefPubMedPubMedCentral Pasternak M, Liu P, Quinn R, et al. Association of Albuminuria and regression of chronic kidney disease in adults with newly diagnosed moderate to severe chronic kidney disease. JAMA Netw Open. 2022;5(8):e2225821.CrossRefPubMedPubMedCentral
27.
go back to reference Raji YR, Mabayoje MO, Bello BT, et al. Albuminuria and reduced estimated glomerular filtration rate among first-degree relatives of patients with chronic kidney disease in Lagos, Southwest Nigeria. Indian J Nephrol. 2018;28(1):21.CrossRefPubMedPubMedCentral Raji YR, Mabayoje MO, Bello BT, et al. Albuminuria and reduced estimated glomerular filtration rate among first-degree relatives of patients with chronic kidney disease in Lagos, Southwest Nigeria. Indian J Nephrol. 2018;28(1):21.CrossRefPubMedPubMedCentral
28.
go back to reference Norris KC, Smoyer KE, Rolland C et al. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 2018;19(1). Norris KC, Smoyer KE, Rolland C et al. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 2018;19(1).
29.
go back to reference Consortium CKDP. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.CrossRef Consortium CKDP. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.CrossRef
30.
go back to reference Sharma P, McCullough K, Scotland G, et al. Does stage-3 chronic kidney disease matter? A systematic literature review. Br J Gen Pract. 2010;60(575):e266–76.CrossRefPubMedCentral Sharma P, McCullough K, Scotland G, et al. Does stage-3 chronic kidney disease matter? A systematic literature review. Br J Gen Pract. 2010;60(575):e266–76.CrossRefPubMedCentral
31.
go back to reference Martínez-Ramírez HR, Cortés-Sanabria L, Rojas-Campos E, et al. Multidisciplinary strategies in the management of early chronic kidney disease. Arch Med Res. 2013;44(8):611–5.CrossRefPubMed Martínez-Ramírez HR, Cortés-Sanabria L, Rojas-Campos E, et al. Multidisciplinary strategies in the management of early chronic kidney disease. Arch Med Res. 2013;44(8):611–5.CrossRefPubMed
Metadata
Title
Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry
Authors
Yun-Kai Yeh
Kuan-Hung Lin
Wayne Huey-Herng Sheu
Su-Huey Lo
Yen-Po Yeh
Chien-Ning Huang
Chii-Min Hwu
Chieh-Hsiang Lu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03567-1

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.